Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2021 | 11-2020 | 08-2020 | 05-2020 | 02-2020 | |
| Sales | 2,258 | 1,368 | 585 | 764 | 668 |
| Cost of Goods | 163 | 285 | 1,046 | 48 | 198 |
| Gross Profit | 2,095 | 1,083 | -461 | 716 | 470 |
| Operating Expenses | 2,452 | 2,661 | 2,975 | 2,919 | 3,960 |
| Operating Income | -357 | -1,578 | -3,436 | -2,204 | -3,490 |
| Interest Expense | 389 | 336 | 301 | 345 | 355 |
| Other Income | -117 | -1,582 | -171 | 41 | 108 |
| Pre-tax Income | -863 | -3,495 | -3,909 | -2,507 | -3,737 |
| Net Income Continuous | -863 | -3,495 | -3,909 | -2,507 | -3,737 |
| Minority Interests | 0 | 0 | 50 | 132 | 208 |
| Net Income | $-863 | $-3,495 | $-3,860 | $-2,375 | $-3,529 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EBITDA(a) | $277 | $-2,451 | $-2,884 | $-1,609 | $-2,657 |